Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1244Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mrs.Chudamani B | - |
| dc.date.accessioned | 2022-12-22T08:18:14Z | - |
| dc.date.available | 2022-12-22T08:18:14Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1244 | - |
| dc.description.abstract | Cancer is responsible for millions of death every year. The drugs used to treat cancer bear severe side-effects. Hence, there is always a need for effective and safer molecules against it. It can be achieved either by screening the NCE or repurposing the existing one. The bioisosteric replacement on a synthetically versatile scaffold often gives the molecule with desired biological properties. In-silico analysis of existing drugs is also in use to find new anticancer moiety. Cell line based study, heterocyclic synthesis and CADD play vital role inthe process. Objectives: Objectives of the work is to design, synthesize and screen 2,6-substituted-imidazo[2,1-b] [1,3,4]thiadiazoles as levamisole derivativewith desired cytotoxic property and convert them to a potential lead against cancer. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | 2-Aralkyl-6-aryl-imidazo[2,1-b][1,3,4]thiadiazole;Cytotoxicity;Apoptosis; Caspase-3; DNA fragmentation;Levamisole;Melplhalan | en_US |
| dc.title | Synthesis Of Levamisole Derivatives For Anti Cancer Activity | en_US |
| dc.type | Phd Thesis | en_US |
| Appears in Collections: | Faculty of Pharmacy | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Chudamani B.pdf | 5.6 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.